Bayesian Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bayesian Capital Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,100	Closed	-$206K	–	609
2021 Q2	$206K	Buy	+6,100	New	+$155K	0.05%	362

Bayesian Capital Management's CNST Position: Q3 2021 in Review

Bayesian Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 6,100 shares — an estimated $206K sold.

Bayesian Capital Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $206K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Bayesian Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Bayesian Capital Management sold 6,100 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $206K.
Bayesian Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Bayesian Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $206K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Bayesian Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.